当前位置:首页 - 行情中心 - 大博医疗(002901) - 财务分析 - 现金流量表

大博医疗

(002901)

  

流通市值:109.85亿  总市值:129.71亿
流通股本:3.51亿   总股本:4.14亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,833,258,921.811,323,248,289.94847,083,871.67357,397,127.42
收到的税费返还4,026,436.183,994,230.022,863,182.3-
收到其他与经营活动有关的现金224,426,641.24126,137,587.2584,306,520.8165,277,226.1
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,061,711,999.231,453,380,107.21934,253,574.78422,674,353.52
购买商品、接受劳务支付的现金662,047,521.29502,379,069.43343,552,729.01178,424,804.49
支付给职工以及为职工支付的现金612,323,221.66465,113,830.58318,361,602179,350,670.4
支付的各项税费110,528,247.49100,285,156.7276,950,731.7630,119,311.07
支付其他与经营活动有关的现金602,951,042.49375,205,468.14252,462,035.68136,189,053.08
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,987,850,032.931,442,983,524.87991,327,098.45524,083,839.04
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额73,861,966.310,396,582.34-57,073,523.67-101,409,485.52
二、投资活动产生的现金流量:
收回投资收到的现金1,605,138,2981,085,138,298819,738,298520,683,214.23
取得投资收益收到的现金11,928,323.156,606,030.213,779,096.953,228,672.24
处置固定资产、无形资产和其他长期资产收回的现金净额1,590,904.72480,854.66196,394.6610,532.8
收到的其他与投资活动有关的现金419,452,091.46362,243,111.54304,713,778.94276,801,249.72
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,038,109,617.331,454,468,294.411,128,427,568.55800,723,668.99
购建固定资产、无形资产和其他长期资产支付的现金305,716,542.81222,598,375.3163,311,058.5172,546,033.21
投资支付的现金1,675,836,7981,215,837,298827,838,298539,606,271
支付其他与投资活动有关的现金564,568,943.45476,373,781.78330,764,397.78228,692,777.78
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,546,122,284.261,914,809,455.081,321,913,754.29840,845,081.99
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-508,012,666.93-460,341,160.67-193,486,185.74-40,121,413
三、筹资活动产生的现金流量:
取得借款收到的现金532,497,020.83410,040,864.83292,940,666109,714,817
收到其他与筹资活动有关的现金163,500113,100--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计532,660,520.83410,153,964.83292,940,666109,714,817
偿还债务支付的现金2,000,0001,300,000700,000-
分配股利、利润或偿付利息支付的现金24,130,559.8220,228,800.4717,213,026.35598,832.01
其中:子公司支付给少数股东的股利、利润14,700,00014,700,00014,700,000-
支付其他与筹资活动有关的现金10,326,292.497,230,402.515,148,851.351,708,109.02
筹资活动现金流出平衡项目0000
筹资活动现金流出小计36,456,852.3128,759,202.9823,061,877.72,306,941.03
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额496,203,668.52381,394,761.85269,878,788.3107,407,875.97
四、汇率变动对现金及现金等价物的影响1,057,295.47-819,318.92-59,401.39-248,241.53
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额63,110,263.36-69,369,135.419,259,677.5-34,371,264.08
加:期初现金及现金等价物余额214,053,885.56214,053,885.56214,053,885.56214,053,885.56
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额277,164,148.92144,684,750.16233,313,563.06179,682,621.48
补充资料:
净利润86,336,019.21-101,704,297.63-
资产减值准备49,219,282.31-5,148,129.45-
固定资产和投资性房地产折旧89,066,409.65-44,701,279.42-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧89,066,409.65-44,701,279.42-
无形资产摊销12,741,558.28-6,110,337.44-
长期待摊费用摊销82,491,925.85-35,489,226.14-
处置固定资产、无形资产和其他长期资产的损失-302,702.99--173,882.78-
固定资产报废损失22,814.07-23,258.9-
公允价值变动损失-5,601,864.97--321,122.22-
财务费用-19,387,378.17--16,918,434.47-
投资损失-9,746,765.11--3,779,096.95-
递延所得税-3,815,577.86--732,862.38-
其中:递延所得税资产减少-1,886,587.35-1,734,317.49-
递延所得税负债增加-1,928,990.51--2,467,179.87-
存货的减少-422,180,024.14--215,271,654.05-
经营性应收项目的减少86,797,180.36--41,859,574.79-
经营性应付项目的增加118,133,691.31-23,839,458.1-
现金的期末余额277,164,148.92-233,313,563.06-
减:现金的期初余额214,053,885.56-214,053,885.56-
公告日期2024-03-302023-10-272023-08-312023-04-29
审计意见(境内)标准无保留意见
TOP↑